Author

David Nahamya

Observed name: Nahamya, David

Institution: National Drug Authority

Observed institution: National Drug Authority

OpenAlex ID: A5088330518

Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study

2012 · Ambrose O Talisuna, Penny Grewal Daumerie, et al. · Malaria Journal · 28

Overcoming the affordability barrier for effective and high quality life saving malaria medicines in the private sector in rural Uganda: the Consortium for ACT Private Sector Subsidy (CAPSS) pilot study

2012 · Ambrose O Talisuna, Penny Grevval, et al. · Malaria Journal · 17

The role of constraints and information gaps in driving risky medicine purchasing practices in four African countries

2024 · Janelle M Wagnild, Nasima Akhter, et al. · Health Policy and Planning · 10

The impact of the increase in import verification fees on local production capacity of selected medicines in Uganda

2023 · Kalidi Rajab, Solomon Onen, et al. · Journal of Pharmaceutical Policy and Practice · 6

Cost and availability of selected medicines after implementation of increased import verification fees

2024 · Helen Byomire Ndagije, Diana Nakitto Kesi, et al. · BMC Health Services Research · 5

Inter-rater reliability and validity of good pharmacy practices measures in inspection of public sector health facility pharmacies in Uganda

2019 · Brian Sekayombya, David Nahamya, et al. · Journal of Pharmaceutical Policy and Practice · 4

Assessment of essential drug management in the public health facilities in Uganda

2007 · David Nahamya · Open University of Cape Town (University of Cape Town) · 4

Advancing Pharmacovigilance Practice in Africa: Moving from Data Collection to Data-Driven Decision Making—Report from the 4th ISoP Africa Chapter Meeting

2025 · Helen Byomire Ndagije, Sheila Ampaire, et al. · Drug Safety · 3

Suggested Improvements to the Current East African Community Medicines Regulatory Harmonization Joint Review Process and a Proposed New Review Model for this Initiative

2025 · Nancy Ngum, Chimwemwe Chamdimba, et al. · Pharmaceutical Medicine · 3

Can public education campaigns equitably counter the use of substandard and falsified medical products in African countries?

2025 · Janelle M Wagnild, Samuel Asiedu Owusu, et al. · Health Policy and Planning · 3

Correction: Advancing Pharmacovigilance Practice in Africa: Moving from Data Collection to Data-Driven Decision Making—Report from the 4th ISoP Africa Chapter Meeting

2026 · Helen Byomire Ndagije, Sheila Ampaire, et al. · Drug Safety · 1

Works count: 17

Citation count: 84

H-index: 5

I10-index: 3